Haohai lands $304m in red-hot HK listing

Shanghai Haohai Biological Technology’s HK$2.36bn ($304m) IPO received a rousing reception, allowing bookbuilding to wrap up sooner than planned as booming demand led to the shares pricing at the top of the range.